Huntington National Bank Sells 306 Shares of Agilent Technologies, Inc. (NYSE:A)

Huntington National Bank reduced its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 9.9% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,779 shares of the medical research company’s stock after selling 306 shares during the period. Huntington National Bank’s holdings in Agilent Technologies were worth $413,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in A. Cetera Investment Advisers raised its stake in shares of Agilent Technologies by 953.3% in the first quarter. Cetera Investment Advisers now owns 32,694 shares of the medical research company’s stock valued at $4,757,000 after acquiring an additional 29,590 shares during the last quarter. iA Global Asset Management Inc. raised its position in Agilent Technologies by 26.2% in the 1st quarter. iA Global Asset Management Inc. now owns 21,770 shares of the medical research company’s stock valued at $3,168,000 after purchasing an additional 4,523 shares during the last quarter. Bayesian Capital Management LP acquired a new position in Agilent Technologies in the first quarter worth $1,355,000. Marshall Financial Group LLC bought a new stake in shares of Agilent Technologies during the second quarter worth $1,058,000. Finally, Vanguard Group Inc. increased its stake in shares of Agilent Technologies by 18.2% in the first quarter. Vanguard Group Inc. now owns 29,884,345 shares of the medical research company’s stock valued at $4,348,471,000 after buying an additional 4,605,228 shares in the last quarter.

Agilent Technologies Price Performance

Shares of NYSE A opened at $127.07 on Friday. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. The firm’s 50-day moving average price is $138.73 and its 200-day moving average price is $138.00. The firm has a market capitalization of $36.51 billion, a P/E ratio of 26.36, a P/E/G ratio of 5.91 and a beta of 1.07. Agilent Technologies, Inc. has a 1-year low of $112.06 and a 1-year high of $155.35.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.06. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The company had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same quarter in the previous year, the firm earned $1.43 earnings per share. Agilent Technologies’s quarterly revenue was down 5.6% on a year-over-year basis. Equities research analysts anticipate that Agilent Technologies, Inc. will post 5.24 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st were given a dividend of $0.236 per share. The ex-dividend date was Tuesday, October 1st. This represents a $0.94 annualized dividend and a yield of 0.74%. Agilent Technologies’s payout ratio is currently 19.50%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on A shares. Barclays upped their target price on shares of Agilent Technologies from $135.00 to $145.00 and gave the stock an “underweight” rating in a research report on Tuesday, October 15th. Stifel Nicolaus reiterated a “buy” rating and issued a $151.00 price objective on shares of Agilent Technologies in a research report on Monday, August 26th. Citigroup boosted their target price on Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Bank of America raised their price target on Agilent Technologies from $140.00 to $147.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. Finally, TD Cowen boosted their price objective on Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. One analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $144.36.

Insider Buying and Selling

In other news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the transaction, the chief executive officer now owns 24,118 shares in the company, valued at $3,497,110. This trade represents a 7.51 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Dominique Grau sold 9,990 shares of the company’s stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the sale, the senior vice president now owns 40,011 shares in the company, valued at $5,801,595. The trade was a 19.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 11,995 shares of company stock worth $1,739,510.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.